The role of dopaminergic systems in opioid receptor desensitization in nucleus accumbens and caudate putamen of rat after chronic morphine treatment

Journal of Pharmacology and Experimental Therapeutics

Volumn 283, Issue 2, 1997, Pages 557-565

  Noble, Florence ^a,b   Cox, Brian M ^b  

^a Laboratoire de Pharmacochimie   (France)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; ADENOSINE A2A RECEPTOR; ADENOSINE TRIPHOSPHATE; ADENYLATE CYCLASE; CYCLIC AMP; DELTA OPIATE RECEPTOR; DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; EGTAZIC ACID; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; ETICLOPRIDE; GUANOSINE TRIPHOSPHATE; MORPHINE SULFATE; MU OPIATE RECEPTOR; OPIATE RECEPTOR; QUINELORANE; THEOPHYLLINE;

ADAPTATION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CAUDATE NUCLEUS; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; ENZYME ACTIVITY; GENE EXPRESSION REGULATION; LONG TERM CARE; MALE; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PUTAMEN; RAT; RECEPTOR DOWN REGULATION; SUBCUTANEOUS DRUG ADMINISTRATION;

(R)-2,3,4,5-TETRAHYDRO-8-CHLORO-3-METHYL-5-PHENYL-1H-3-BENZAZEPIN-7-OL; 2,3,4,5-TETRAHYDRO-7,8-DIHYDROXY-1-PHENYL-1H-3-BENZAZEPINE; ADENOSINE; ADENYLATE CYCLASE; ANIMALS; MALE; MORPHINE; NUCLEUS ACCUMBENS; PHENETHYLAMINES; PUTAMEN; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D2; RECEPTORS, OPIOID, DELTA;

EID: 0030733862     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. ANGULO, J. A. AND MCEWEN, B. S.: Molecular aspects of neuropeptide regulation and function in the corpus striatum and nucleus accumbens. Brain Res. Rev. 19: 1-28, 1994.
2. 2a receptor mRNA is expressed by enkephalin cells but not by somatostatin cells in rat striatum: A co-expression study. Mol. Brain Res. 22: 204-210, 1994.
3. 1 dopamine receptor antagonism. Eur. J. Pharmacol. 128: 249-253, 1986.
4. BEITNER-JOHNSON, D., GUITART, X., NESTLER, E. J.: Neurofilament proteins and the mesolimbic dopamine system: Common regulation by chronic morphine and chronic cocaine in the rat ventral tegmental area. J. Neurosci. 12: 2165-2176, 1992.
5. BENOVIC, J. L., STRASSER, R. H., DANIEL K. AND LEFKOWITZ, R. J.: Beta-adrenergic receptor kinase: Identification of a novel protein kinase that phosphorylates the agonist-occupied form of the receptor. Proc. Natl. Acad. Sci. U.S.A. 83: 2797-2801, 1986.
6. BOZARTH, M. A.: Neural basis of psychomotor stimulant and opiate reward: Evidence suggesting the involvement of a common dopaminergic system. Behav. Brain Res. 22: 107-115, 1986.
7. BROWN, B. L., ALBANO, J. D. M., EKINS, R. P., SGHERZI, A. M., TAMPION, W.: A simple and sensitive saturation assay method for measurement of adenosine 3′,5′-cyclic monophosphate. Biochem. J. 121: 561-562, 1971.
8. BÙZÀs, B., IZENWASSER, S., PORTOGHESE, P. S., COX, B. M.: Evidence for delta opioid receptor subtypes regulating adenylyl cyclase activity in rat brain. Life Sci. 54: PL101-106, 1994.
9. CADOR, M., TAYLOR, J. R., ROBBINS, T. W.: Potentiation of the effects of reward-related stimuli by dopaminergic dependent mechanisms in the nucleus accumbens. Psychopharmacology 104: 377-382, 1991.
10. CAMERON, D. L. AND WILLIAMS, J. T.: Dopamine D1 receptors facilitate transmitter release. Nature (Lond.) 366: 344-347, 1993.
11. CHILDERS, S. R.: Opioid receptor-coupled second messenger systems. Life Sci. 48: 1991-2003, 1991.
12. DUMAN, R. S., TALLMAN, J. F. AND NESTLER, E. J.: Acute and chronic opiate-regulation of adenylate cyclase in brain: Specific effects in locus ceruleus. J. Pharmacol. Exp. Ther. 246: 1033-1039, 1988.
13. ERSPAMER, V., MELCHIORRI, P., FALCONIERI-ERSPAMER, G., NEGRI, L., CORSI, R., SEVERINI, C., BARRA, D., SIMMACO, M. AND KREIL, G.: Deltorphins: A family of naturally occurring peptides with high affinity and selectivity for δ opioid binding sites. Proc. Natl. Acad. Sci. U.S.A. 86: 5188-5192, 1989.
14. GERFEN, C. R.: The neostriatal mosaic: Multiple levels of compartmental organization. Trends Neurosci. 15: 133-139, 1992.
15. 2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science (Wash, DC) 250: 1429-1432, 1990.
16. GERFEN, C. R. AND YOUNG, W. S.: Distribution of striatonigral and striatopallidal peptidergic neurons in both patch and matrix compartments: An in situ hybridization histochemistry and fluorescent retrograde tracing study. Brain Res. 460: 161-167, 1988.
17. GOEDERS, N. E., LANE, J. D. AND SMITH, J. E.: Self-administration of methionine enkephalin into the nucleus accumbens. Pharmacol. Biochem. Behav. 20: 541-546, 1984.
18. 2 receptors in the rat brain. Eur. J. Pharmacol. 111: 191-198, 1985.
19. HAND, T. H. AND FRANKLIN, K. B. J.: 6-OHDA lesions of the ventral tegmental area block morphine-induced but not amphetamine-induced facilitation of self-stimulation. Brain Res. 328: 233-239, 1985.
20. HARRIS, G. C. AND WILLIAMS, J. T.: Transient homologous μ-opioid receptor desensitization in rat locus coeruleus neurons. J. Neurosci. 11: 2574-2581, 1991.
21. HYTTEL, J.: SCH-23390, the first selective dopamine D-1 antagonist. Eur. J. Pharmacol. 91: 153-154, 1983.
22. IZENWASSER, S., BÙZÀS, B. AND COX, B. M.: Differential regulation of adenylyl cvclase activity by mu and delta opioids in rat caudate putamen and nucleus accumbens. J. Pharmacol. Exp. Ther. 267: 145-152, 1993.
23. IZENWASSER, S., HELLER, B. AND COX, B. M.: Continuous cocaine administration enhances μ but not δ-opioid receptor-mediated inhibition of adenylyl cyclase activity in nucleus accumbens. Eur. J. Pharmacol. 297: 187-191, 1996.
24. 6]-enkephalin and naltrindole 5′-isothiocyanate: Evidence for delta receptor subtypes. J. Pharmacol. Exp. Ther. 257: 1069-1075, 1991.
25. JOHNSON, S. W. AND NORTH, R. A.: Opioids excite dopamine neurons by hyperpolarization of local interneurons. J. Neurosci. 12: 483-488, 1992.
26. LAW, P. Y., HOM, D. S. AND LOH, H. H.: Opiate receptor down-regulation and desensitization in neuroblastoma × glioma NG 108-15 hybrid cells are two separate cellular adaptation processes. Mol. Pharmacol. 24: 413-424, 1983.
27. LE MOINE, C., NORMAND, E., GUITTENY, A. F., FOUQUÚ, B., TÉOULE, R. AND BLOCH, B.: Dopamine receptor gene expression by enkephalin neurons in rat forebrain. Proc. Natl. Acad. Sci. U.S.A. 87: 230-234, 1990.
28. LEFKOWITZ, R. L., HAUSDORFF, W. P. AND CARON, M. G.: Role of phosphorylation in desensitization of the β-adrenoceptor. Trends Pharmacol. Sci. 11: 190-194, 1990.
29. MATSUOKA, I., MALDONADO, R., DEFER, N., NOëL, F., HANOUNE, J. AND ROQUES, B. P.: Chronic morphine administration causes region-specific increase of brain type VIII adenylyl cyclase mRNA. Eur. J. Pharmacol. (Mol. Pharmacol. Sec.) 268: 215-221, 1994.
30. MATTHES, H. W. D., MALDONADO, R., SIMONIN, F., VALVERDE, O., SLOWE, S., KITCHEN, I., BEFORT, K., DIERICH, A., LE MEUR, M., DOLLÉ, P., TZAVARA, E., HANOUNE, J., ROQUES, B. P. AND KIEFFER, B. L.: Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the μ-opioid-receptor gene. Nature (Lond) 383: 819-823, 1996.
31. 2] del torphine II in mice: Evidence for delta receptor subtypes. J. Pharmacol. Exp. Ther. 258: 583-587, 1991.
32. MOSBERG, H. I., HURST, R., HRUBY, V. I., GEE, K., YAMAMURA, H. L., GALLIGAN, J. J. AND BURKS, T. F.: Bis-penicillamine enkephalins show pronounced delta receptor selectivity. Proc. Natl. Acad. Sci. U.S.A. 80: 5871-5874, 1983.
33. NESTLER, E. J., ERDOS, J. J., TERWILLIGER, R., DUMAN, R. S. AND TALLMAN, J. F.: Regulation of G-proteins by chronic morphine in the rat locus coeruleus. Brain Res. 476: 230-239, 1989.
34. NESTLER, E. J. AND TALLMAN, J. F.: Chronic morphine treatment increases cyclic AMP-dependent protein kinase activity in the rat locus coeruleus. Mol. Pharmacol. 33: 127-132, 1988.
35. NICOLL, R. A., ALGER, B. E. AND JAHR, C. E.: Enkephalin blocks inhibitory pathways in the mammalian CNS. Nature (Lond.) 287: 22-25, 1980.
36. 2-opioid agonists in rat caudate-putamen. J. Neurochem. 65: 125-133, 1995.
37. NOBLE, F. AND COX, B. M.: Differential desensitization of μ- and δ-opioid receptors in selected neural pathways following chronic morphine treatment. Br. J. Pharmacol. 117: 161-169, 1996.
38. PETERSON, G. L.: A simplification of the protein assay method of Lowry et al. which is more generally applicable. Anal. Biochem. 83: 346-356, 1977.
39. PUTTFARCKEN, P. S., WERLING, L. L. AND COX, B. M.: Effects of chronic morphine exposure on opioid inhibition of adenylyl cyclase in 7315c cell membranes: A useful model for the study of tolerance at μ opioid receptors. Mol. Pharmacol. 33: 520-527, 1988.
40. 2 receptor (RDC8) is expressed by enkephalin but not by substance P neurons: An in situ hybridization histochemistry study. J. Neurochem. 57: 1062-1067, 1991.
41. SHIPPENBERG, T. S. AND HERZ, A.: Motivational effects of opioids: Influence of D-1 versus D-2 receptor antagonists. Eur. J. Pharmacol. 151: 233-242, 1988.
42. SIMMONS, M. A., BECKER, J. B. AND MATHER, R. J.: Desensitization of the inhibition of the M-current in sympathetic neurons: Effects of ATP analogs, polyanions, and multiple agonist applications. Neuron 4: 557-562, 1990.
43. SMITH, J. E., GUERIN, G. F., Co C., BARR, T. S. AND LANE, J. D.: Effects of 6-OHDA lesions of the central medial nucleus accumbens on rat intravenous morphine self-administration. Pharmacol. Biochem. Behav. 23: 843-849, 1985.
44. SOFUOGLU, M., PORTOGHESE, P. S. AND TAKEMORI, A. E.: Differential antagonism of delta opioid agonists by naltrindole and its benzofuran analog (NTB) in mice: Evidence for delta receptor subtypes. J. Pharmacol. Exp. Ther. 257: 676-680, 1991.
45. STILES, G. L.: Adenosine receptors. J. Biol. Chem. 267: 6451-6454, 1992.
46. TERWILLIGER, R. Z., BEITNER-JOHNSON, D., SEVARINO, K. A., CRAIN, S. M. AND NESTLER, E. J.: A general role for adaptations in G-proteins and the cyclic AMP system in mediating the chronic actions of morphine and cocaine on neuronal function. Brain Res. 548: 100-110, 1991.
47. UNTERWALD, E. M., Cox, B. M., KREEK, M. J., CÔTÉ, T. E. AND IZENWASSER, S.: Chronic repeated cocaine administration alters basal and opioid-regulated adenylyl cyclase activity. Synapse 15: 33-38, 1993.
48. 2 dopamine receptors. Mol. Pharmacol. 50: 966-976, 1996.